Table 2.
Outcome measures | VA1, n=12 | VA2, n=14 | VA3, n=15 | SA, n=13 | WT, n=18 | AG, n=54 |
---|---|---|---|---|---|---|
| ||||||
Headache intensity | ||||||
Mean (95%CI) | ||||||
| ||||||
Baseline | 5.33 | 5.32 | 5.80 | 5.46 | 5.58 | 5.49 |
(4.46; 6.20) | (4.77; 5.87) | (5.20; 6.40) | (4.52; 6.40) | (5.14; 6.03) | (5.15; 5.83) | |
| ||||||
End of treatment | 3.25 | 3.57 | 2.87 | 4.19 | 5.53 | 3.45 |
(2.39; 4.11) | (2.83; 4.31) | (2.01; 3.72) | (3.34; 5.04) | (4.69; 6.36) | (3.06; 3.85) | |
| ||||||
P value | 0.003 | 0.000 | 0.000 | 0.083 | 0.869 | 0.000 |
| ||||||
Headache frequency | ||||||
Mean (95%CI) | ||||||
| ||||||
Baseline | 5.75 | 7.50 | 5.73 | 6.00 | 4.50 | 6.26 |
(3.89; 7.61) | (5.61; 9.39) | (3.58; 7.88) | (4.04; 7.96) | (3.07; 5.93) | (5.34; 7.18) | |
| ||||||
End of treatment | 3.92 | 5.93 | 4.20 | 6.15 | 8.17 | 5.06 |
(2.37; 5.46) | (4.38; 7.47) | (2.42; 5.98) | (4.03; 8.27) | (5.81; 10.52) | (4.21; 5.90) | |
| ||||||
P value | 0.014 | 0.021 | 0.013 | 0.895 | 0.001 | 0.003 |
| ||||||
SAS score | ||||||
Mean (95%CI) | ||||||
| ||||||
Baseline | 44.63 | 44.86 | 47.02 | 47.21 | 47.10 | 46.00 |
(39.74; 49.51) | (40.36; 49.35) | (41.69; 52.34) | (42.23; 52.20) | (41.92; 52.26) | (43.71; 48.23) | |
| ||||||
End of treatment | 38.13 | 41.45 | 37.98 | 37.37 | 41.39 | 38.76 |
(31.15; 45.10) | (37.12; 45.78) | (32.61; 43.36) | (33.09; 41.64) | (37.83; 44.94) | (36.36; 41.17) | |
| ||||||
P value | 0.055 | 0.117 | 0.005 | 0.019 | 0.017 | 0.000 |
| ||||||
SDS score | ||||||
Mean (95%CI) | ||||||
| ||||||
Baseline | 42.13 | 48.98 | 44.80 | 45.06 | 46.88 | 45.35 |
(35.01; 49.24) | (43.97; 53.99) | (38.22; 51.38) | (39.25; 50.86) | (42.01; 51.74) | (42.51; 48.20) | |
| ||||||
End of treatment | 40.63 | 42.68 | 39.15 | 37.56 | 41.18 | 40.01 |
(32.17; 49.08) | (37.07; 48.28) | (33.41; 44.89) | (32.06; 43.06) | (36.57; 45.80) | (37.14; 42.88) | |
| ||||||
P value | 0.518 | 0.040 | 0.023 | 0.049 | 0.066 | 0.000 |